Dual Anti‐vascular Function of Human Fibulin‐3 Variant, a Potential New Drug Discovery Strategy for Glioblastoma

Cancer Science - United States
doi 10.1111/cas.14300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery

English

Human Recombinant RNASET2: A Potential Anti-Cancer Drug

Oncoscience
Cancer ResearchOncology
2016English

Traditional Mongolian Medicine – A Potential for Drug Discovery

Scientia Pharmaceutica
Pharmaceutical Science
2008English

Repurposing as a Strategy for the Discovery of New Anti-Leishmanials: The-State-Of-The-Art

Parasitology
Animal ScienceZoologyParasitologyInfectious Diseases
2017English

Human Pluripotent Stem Cells and Drug Discovery: A New Beginning

Defence Life Science Journal
GeneticsMolecular BiologyPharmacologyBiochemistryToxicologyBiological SciencesAgriculturalPharmaceutics
2016English

Characterization of Human iPSC-derived Astrocytes With Potential for Disease Modeling and Drug Discovery

2019English

Epigenetic Protein Families: A New Frontier for Drug Discovery

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2012English

mTOR Mediated Anti-Cancer Drug Discovery

Drug Discovery Today: Therapeutic Strategies
2009English

Potential Therapeutic Effect of Glycogen Synthase Kinase 3 Inhibition Against Human Glioblastoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy